High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
75.73M
+3.61%
0.185
-2.63%
76.63M
+3.23%
0.195
+21.88%
75.91M
+3.3%
0.180
+28.57%
Estimates Revision
The market is revising Downward the revenue expectations for HealthStream, Inc. (HSTM) for FY2025, with the revenue forecasts being adjusted by -1.18% over the past three months. During the same period, the stock price has changed by -2.72%.
Revenue Estimates for FY2025
Revise Downward
-1.18%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+1.41%
In Past 3 Month
Stock Price
Go Down
-2.72%
In Past 3 Month
4 Analyst Rating
0Wall Street analysts forecast HSTM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSTM is 29.00 USD with a low forecast of 29.00 USD and a high forecast of 29.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
2 Hold
0 Sell
Moderate Buy
0Current: 26.090
Low
29.00
Averages
29.00
High
29.00
0Current: 26.090
Low
29.00
Averages
29.00
High
29.00
Canaccord
Richard Close
Hold
downgrade
$30 -> $29
2025-05-15
Reason
Canaccord
Richard Close
Price Target
$30 -> $29
2025-05-15
downgrade
Hold
Reason
Canaccord analyst Richard Close lowered the firm's price target on HealthStream to $29 from $30 and keeps a Hold rating on the shares. The firm said they reported 1Q'25 results which fell below Canaccord and consensus estimates as well as a reduction in 2025 guidance.
Canaccord Genuity
Richard Close
Hold
Maintains
$29 → $30
2025-02-26
Reason
Canaccord Genuity
Richard Close
Price Target
$29 → $30
2025-02-26
Maintains
Hold
Reason
Canaccord analyst Richard Close raised the firm's price target on HealthStream to $30 from $29 and keeps a Hold rating on the shares. The firm said they reported a respectable quarter, with revenue above and adj-EBITDA only slightly below Canaccord and consensus estimates.
JMP Securities
Constantine Davides
Hold
Reiterates
n/a
2025-02-06
Reason
JMP Securities
Constantine Davides
Price Target
n/a
2025-02-06
Reiterates
Hold
Reason
Canaccord Genuity
Richard Close
Hold
Maintains
$28 → $29
2024-10-23
Reason
Canaccord Genuity
Richard Close
Price Target
$28 → $29
2024-10-23
Maintains
Hold
Reason
Canaccord raised the firm's price target on HealthStream to $29 from $28 and keeps a Hold rating on the shares. The firm said they posted another steady quarter and noted the the sales pipeline is strong across core product areas in CredentialStream, ShiftWizard, and API related products. Adoption of APIs and the Developer Portal has continued to gain traction, with the number of organizations and third-party developers accessing the portal roughly doubling in the last twelve months.
See All Ratings
Valuation Metrics
The current forward P/E ratio for HealthStream Inc (HSTM.O) is 34.50, compared to its 5-year average forward P/E of -28.51. For a more detailed relative valuation and DCF analysis to assess HealthStream Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-28.51
Current PE
34.50
Overvalued PE
375.60
Undervalued PE
-432.62
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
13.23
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
15.82
Undervalued EV/EBITDA
10.63
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
2.82
Current PS
0.00
Overvalued PS
3.17
Undervalued PS
2.47
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
HSTM News & Events
Events Timeline
(ET)
2025-08-04
16:36:57
HealthStream sees 2025 revenue $297.5M-$303.5M, consensus $300.25M
2025-08-04
16:35:59
HealthStream reports Q2 EPS 18c, consensus 17c
2025-05-08 (ET)
2025-05-08
16:33:30
HealthStream announces $25M stock buyback
Sign Up For More Events
Sign Up For More Events
News
Preview
9.5
07-25NASDAQ.COMOPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?
Preview
1.0
07-22NewsfilterHealthStream to Host Second Quarter 2025 Earnings Conference Call
Preview
3.5
07-11NASDAQ.COMOptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?
Sign Up For More News
People Also Watch
FAQ
What is HealthStream Inc (HSTM) stock price today?
What is HealthStream Inc (HSTM)'s business?
What is the price predicton of HSTM Stock?
What is HealthStream Inc (HSTM)'s revenue for the last quarter?
What is HealthStream Inc (HSTM)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for HealthStream Inc (HSTM)'s fundamentals?
How many employees does HealthStream Inc (HSTM). have?